J Korean Ophthalmol Soc.
2004 Oct;45(10):1674-1680.
Interferon-alpha in the Treatment of Behcet's Disease
- Affiliations
-
- 1Department of Ophthalmology, Uijongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #65-1 Kumo-dong, Uijongbu city, Kyunggi-do, Korea. saint@catholic.ac.kr
- 2Apgujung St. Mary's Eye Center, Korea.
Abstract
- PURPOSE
To determine the therapeutic efficacy of interferon-alpha on patients with Behcet's disease who have been resistant to conventional therapies. METHODS: We treated 22 eyes of 13 patients with interferon-alpha for a mean of 20.5 months. They were given 3 million units interferon-alpha subcutaneously three times a week. Using slit lamp microscopy, fluorescent angiography, the authors compared visual acuity, frequency of relapse of uveitis and complications of interferon-alpha. RESULTS: The average ocular attack rate fell from 0.41 times a month to 0.19 times after interferon therapy. In addition, the degree of intraocular inflammation and especially retinal vasculitis decreased. There were no side effects significant enough to stop using interferon. CONCLUSIONS: Therapy with interferon-alpha seems to be an effective and safe regimen in Behcet's disease for refractory ocular attack and for the protection of vision.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Treatment of Behcet's disease
- Cutaneous Ulceration after Injection of Interferon Alpha in a Melanoma Patient
- Effect of alpha-interferon treatment on serum ALT levels in patients with chronic hepatitis C
- Effect of alpha-Interferon 2b on Chronic Hepatitis B Patients with High Serum ALT
- Successful Treatment of Child Neuro-Behcet's Disease with Infliximab
